 |
|
Changes in Lp(a) Lipoprotein and Lipid Levels After Cessation of Female Sex Hormone Production and Estrogen Replacement Therapy
Chee Jeong Kim, MD;
Wang Seong Ryu, MD;
Ju Won Kwak, PhD;
Chong Taik Park, MD;
Un Ho Ryoo, MD
Arch Intern Med. 1996;156(5):500-504.
Abstract
| |
Objective
To investigate the serial changes in Lp(a) lipoprotein levels with the loss of female sex hormones by surgical menopause and with estrogen replacement therapy in the same women.
Patients and Methods
Forty-four premenopausal women who underwent a transabdominal hysterectomy (TAH) because of benign gynecological disorders were divided into two groups: women who underwent a TAH and unilateral salpingo-oophorectomy (n=31) and women who underwent a TAH and bilateral salpingo-oophorectomy (n=13). In the group of women who underwent a TAH and bilateral salpingo-oophorectomy, 0.625 mg of conjugated equine estrogen was given daily 2 months after the operation. The levels of Lp(a) lipoprotein and lipids were measured before and at 2 and 4 months after the operation.
Results
In the group of women who underwent a TAH and bilateral salpingo-oophorectomy, the mean (±SD) concentration of Lp(a) lipoprotein was increased by 24.5% from 0.48±0.47 mmol/L (18.4± 18.3 mg/dL) to 0.59±0.54 mmol/L (22.9±21.0 mg/dL) after 2 months (P<.05), and it was reduced by 30.6% to 0.41±0.51 mmol/L (15.9±20.1 mg/dL) (P<.005) with therapy with conjugated equine estrogen (Premarin). The Lp(a) lipoprotein levels were not changed in the group of women who underwent a TAH and unilateral salpingooophorectomy. In the group of women who underwent a TAH and bilateral salpingo-oophorectomy, the high-density lipoprotein cholesterol level showed a trend of increase after 2 months from 1.45±0.48 mmol/L (56.1 ±18.5 mg/dL) to 1.58±0.39 mmol/L (61.2±15.1 mg/dL) without statistical significance, and it revealed a significant elevation to 1.76±0.43 mmol/L (68.2± 16.8 mg/dL) with therapy with conjugated equine estrogen (Premarin) compared with that of the basal level (P<.05).
Conclusions
The Lp(a) lipoprotein levels appear to be closely associated with female sex hormones. This association might play a pivotal role in postmenopausal increases of atherosclerotic diseases and cardioprotective effect of estrogen in postmenopausal women.
(Arch Intern Med. 1996;156:500-504)
Author Affiliations
From the Division of Cardiology, Department of Internal Medicine, Chung-Ang University Medical Center (Drs Kim, Ryu, and Ryoo), and the Department of Obstetrics and Gynecology, Cheil General Hospital (Dr Park), Seoul, Korea, and the Korean Institute of Science and Technique, Taejeon (Dr Kwak).
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati  Twitter
What's this?
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
|
The association between physical activity, cardiorespiratory fitness, and lipoprotein(a) concentrations in a tri-ethnic sample of women: The Cross-Cultural Activity Participation Study
Drowatzky et al.
Vasc Med 2001;6:15-21.
ABSTRACT
A Randomized Trial Comparing the Effect of Casein With That of Soy Protein Containing Varying Amounts of Isoflavones on Plasma Concentrations of Lipids and Lipoproteins
Crouse III et al.
Arch Intern Med 1999;159:2070-2076.
ABSTRACT
| FULL TEXT
Lipoprotein(a)-Cholesterol and Coronary Heart Disease in the Framingham Heart Study
Seman et al.
Clin. Chem. 1999;45:1039-1046.
ABSTRACT
| FULL TEXT
Transgenic mice expressing a human apolipoprotein[a] allele
Acquati et al.
J. Lipid Res. 1999;40:994-1006.
ABSTRACT
| FULL TEXT
Metabolism of Apo(a) and ApoB100 of Lipoprotein(a) in Women: Effect of Postmenopausal Estrogen Replacement
Su et al.
J. Clin. Endocrinol. Metab. 1998;83:3267-3276.
ABSTRACT
| FULL TEXT
Effect of Postmenopausal Hormone Therapy on Lipoprotein(a) Concentration
Espeland et al.
Circulation 1998;97:979-986.
ABSTRACT
| FULL TEXT
Lipoprotein(a) as a Determinant of Coronary Heart Disease in Young Women: A Stronger Risk Factor Than Diabetes? • Response
Enas and Orth-Gomer
Circulation 1998;97:293-295.
FULL TEXT
Oral 17{beta}-Estradiol Continuously Combined with Dydrogesterone Lowers Serum Lipoprotein(a) Concentrations in Healthy Postmenopausal Women
Mijatovic et al.
J. Clin. Endocrinol. Metab. 1997;82:3543-3547.
ABSTRACT
| FULL TEXT
Effects of Estrus Cycle, Ovariectomy, and Treatment with Estrogen, Tamoxifen, and Progesterone on Apolipoprotein(a) Gene Expression in Transgenic Mice
Zysow et al.
Arterioscler. Thromb. Vasc. Bio. 1997;17:1741-1745.
ABSTRACT
| FULL TEXT
|
